Company intelligence / Profile preview

Grandsoul Research Institute for Immunology

Uda, Nara, Japan

Ownership: Private
Development stage: Other

Overview

The company specializes in cancer immunotherapy research, including neoantigen identification for peptide and dendritic cell vaccines, and has published peer-reviewed studies utilizing human PBMCs and proprietary cryopreservation reagents (CELLBANKER)

Therapeutic areas: Oncology
Modalities: Cell therapyGene therapyVaccineDendritic cell therapyPeptides
Industry: Biotech

Drug pipeline

1 asset

EvCAR-KHYG-1

Preclinical

Partnerships

Clinics such as Clinic Grandsoul, NaraNara Medical University (research publications)

Beyond the preview

Go deeper on Grandsoul Research Institute for Immunology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grandsoul Research Institute for Immunology.

Explore the full profile